The Effects and Mechanism of SGLT2 Inhibitors in Stage B of Heart Failure With Hypertension
Conditions: Heart Failure; Hypertension; Left Ventricle Remodeling; Left Atrial Dilatation Interventions: Drug: Empagliflozin 10 MG; Drug: Placebo Sponsors: China National Center for Cardiovascular Diseases Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Cardiovascular | China Health | Empagliflozin | Heart | Heart Failure | Hypertension | Jardiance | Research | SGLT2 Inhibitors